Matches in SemOpenAlex for { <https://semopenalex.org/work/W3147788682> ?p ?o ?g. }
- W3147788682 abstract "Background and objective: Although the treatment of chronic hepatitis C (CHC) has significantly evolved with the introduction of direct-acting antivirals, the treatment uptake rates have been low especially among marginalized groups in the UK, such as people who inject drug (PWID) and men who have sex with men (MSM). Cutting health inequality is a major focus of healthcare agencies. This study aims to identify the optimal allocation of treatment budget for chronic hepatitis CHC among populations and treatments in the UK so that liver-related mortality in patients with CHC is minimized, given the constraint of treatment budget and equity issue.Methods: A constrained optimization modelling of resource allocation for the treatment of CHC was developed in Excel from the perspective of the UK National Health System over a lifetime horizon. The model was designated with the objective function of minimizing liver-related deaths by varying the decision variables, representing the number of patients receiving each treatment (elbasvir-grazoprevir, ombitasvir-paritaprevir-ritonavir-dasabuvir, sofosbuvir-ledipasvir, and pegylated interferon-ribavirin) in each population (the general population, PWID, and MSM). Two main constraints were formulated including treatment budget and the issue of equity. The model was populated with UK local data applying linear programming and underwent internal and external validation. Scenario analyses were performed to assess the robustness of model results.Results: Within the constraints of no additional funding over original spending in status quo and the consideration of the issue of equity among populations, the optimal allocation from the constrained optimization modelling (treating 13,122 PWID, 160 MSM, and 904 general patients with ombitasvir-paritaprevir-ritonavir-dasabuvir) was found to treat 2,430 more patients (relative change: 20.7%) and avert 78 liver-related deaths (relative change: 0.3%) compared with the current allocation. The number of patients receiving treatment increased 4,928 (relative change: 60.1%) among PWID and 42 (relative change: 35.8%) among MSM.Conclusion: The current allocation of treatment budget for CHC is not optimal in the UK. More patients would be treated, and more liver-related deaths would be avoided using a new allocation from a constrained optimization modelling without incurring additional spending and considering the issue of equity." @default.
- W3147788682 created "2021-04-13" @default.
- W3147788682 creator A5005414117 @default.
- W3147788682 creator A5009030222 @default.
- W3147788682 creator A5010515412 @default.
- W3147788682 creator A5021151483 @default.
- W3147788682 creator A5021893934 @default.
- W3147788682 creator A5064197337 @default.
- W3147788682 date "2021-01-01" @default.
- W3147788682 modified "2023-10-01" @default.
- W3147788682 title "Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach" @default.
- W3147788682 cites W122108692 @default.
- W3147788682 cites W1510386142 @default.
- W3147788682 cites W1550170030 @default.
- W3147788682 cites W1582726555 @default.
- W3147788682 cites W1895311754 @default.
- W3147788682 cites W1948043688 @default.
- W3147788682 cites W1964273353 @default.
- W3147788682 cites W1965862609 @default.
- W3147788682 cites W1969875939 @default.
- W3147788682 cites W1975401342 @default.
- W3147788682 cites W1978757531 @default.
- W3147788682 cites W1980076527 @default.
- W3147788682 cites W1984413237 @default.
- W3147788682 cites W1984436733 @default.
- W3147788682 cites W1991465053 @default.
- W3147788682 cites W1993522535 @default.
- W3147788682 cites W2003646255 @default.
- W3147788682 cites W2004823945 @default.
- W3147788682 cites W2006747389 @default.
- W3147788682 cites W2008450381 @default.
- W3147788682 cites W2011437704 @default.
- W3147788682 cites W2015825865 @default.
- W3147788682 cites W2021704384 @default.
- W3147788682 cites W2027689857 @default.
- W3147788682 cites W2041643208 @default.
- W3147788682 cites W2044287878 @default.
- W3147788682 cites W2044734932 @default.
- W3147788682 cites W2050700128 @default.
- W3147788682 cites W2064184286 @default.
- W3147788682 cites W2064239845 @default.
- W3147788682 cites W2065589382 @default.
- W3147788682 cites W2071067540 @default.
- W3147788682 cites W2077591295 @default.
- W3147788682 cites W2088677683 @default.
- W3147788682 cites W2089106363 @default.
- W3147788682 cites W2090995231 @default.
- W3147788682 cites W2091338138 @default.
- W3147788682 cites W2093867890 @default.
- W3147788682 cites W2115399503 @default.
- W3147788682 cites W2137300636 @default.
- W3147788682 cites W2143048072 @default.
- W3147788682 cites W2143995619 @default.
- W3147788682 cites W2147404007 @default.
- W3147788682 cites W2150543014 @default.
- W3147788682 cites W2158806421 @default.
- W3147788682 cites W2159898970 @default.
- W3147788682 cites W2160124272 @default.
- W3147788682 cites W2164335200 @default.
- W3147788682 cites W2170861144 @default.
- W3147788682 cites W2254064555 @default.
- W3147788682 cites W2298240082 @default.
- W3147788682 cites W2334770329 @default.
- W3147788682 cites W2345197548 @default.
- W3147788682 cites W2354037318 @default.
- W3147788682 cites W2406118020 @default.
- W3147788682 cites W2513898142 @default.
- W3147788682 cites W2513994493 @default.
- W3147788682 cites W2547264935 @default.
- W3147788682 cites W2595777679 @default.
- W3147788682 cites W2596640152 @default.
- W3147788682 cites W2762789262 @default.
- W3147788682 cites W2784263228 @default.
- W3147788682 cites W2784302838 @default.
- W3147788682 cites W2789691427 @default.
- W3147788682 cites W2799828712 @default.
- W3147788682 cites W2802389008 @default.
- W3147788682 cites W2892210399 @default.
- W3147788682 cites W2900411290 @default.
- W3147788682 cites W2906514205 @default.
- W3147788682 cites W2945149169 @default.
- W3147788682 cites W2963850354 @default.
- W3147788682 cites W2964315312 @default.
- W3147788682 cites W2964469891 @default.
- W3147788682 cites W2984008258 @default.
- W3147788682 cites W2996569926 @default.
- W3147788682 cites W3012573025 @default.
- W3147788682 cites W4245234060 @default.
- W3147788682 doi "https://doi.org/10.1080/20016689.2021.1887664" @default.
- W3147788682 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8008927" @default.
- W3147788682 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33828822" @default.
- W3147788682 hasPublicationYear "2021" @default.
- W3147788682 type Work @default.
- W3147788682 sameAs 3147788682 @default.
- W3147788682 citedByCount "2" @default.
- W3147788682 countsByYear W31477886822022 @default.
- W3147788682 countsByYear W31477886822023 @default.
- W3147788682 crossrefType "journal-article" @default.
- W3147788682 hasAuthorship W3147788682A5005414117 @default.
- W3147788682 hasAuthorship W3147788682A5009030222 @default.